🔎 Trials Near Me

Gara Jalqabaatti › Obesity › Texas

Qorannoo klinikaalii Obesity Texas keessatti

Qorannoo 81 Obesity f Texas keessatti hirmaatuu jiru.

Magaalota Texas keessatti

Takkalaa qorannoo (Ingiliffa)

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Elligo Clinical Research Center, Austin
  • Johnson County Clinical Trials Juno Bellaire, Bellaire
  • Cedar Health Research, LLC, Dallas
  • fi 8 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Elligo Clinical Research Center, Austin
  • Johnson County Clinical Trials Juno Bellaire, Bellaire
  • Osvaldo A Brusco MD PA, Corpus Christi
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07684144

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • PharmaTex Research, LLC, Amarillo
  • Austin Heart, Austin
  • Velocity Clinical Research - Austin, Austin
  • fi 22 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 45 hanga 99 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07037433

The RESET System Pivotal Clinical Trial (Protocol Revision H)

  • Baylor College of Medicine, Houston
Namoota walitti qabaa jira
Umuriin 22 hanga 65 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04101669

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

  • Amarillo Medical Specialists /ID# 282380, Amarillo
  • Elligo Clinical Research Center /ID# 282166, Austin
  • JCCT - Juno Bellaire /ID# 282263, Bellaire
  • fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07752979

A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide

  • Kailera Clinical Site, San Antonio
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 85 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07793929

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • DM Clinical, Houston
  • DM Clinical, San Antonio
  • The Texas Liver Institute, San Antonio
  • fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 8 hanga 18 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07253285

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Horizon Clinical Research Group, Cypress
  • Cardiovascular Specialists of Willowbrook, Houston
  • Texas Cardiology Associates of Houston, Kingwood
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07783802

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  • UT Southwestern Med Center, Dallas
  • PlanIt Research, PLLC, Houston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07533175

Spinal Cord Injury Model Systems (SCIMS) - Education Module

  • Baylor Scott & White Institute for Research, Dallas
Namoota walitti qabaa jira
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06003686

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
  • VIP Trials, San Antonio
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07595549

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

  • Endeavor Clinical Trials, San Antonio
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07399678

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • Amarillo Med Spec LLP, Amarillo
  • Texas Diabetes & Endocrinology, Austin
  • Pinnacle Clinical Research, Brownsville
  • fi 7 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07668414

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Amarillo Medical Specialists, Amarillo
  • North Texas Endocrine Center, Dallas
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07720271

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
  • Tyler Research Institute, Tyler
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Dell Children's Medical Center - PIN, Austin
  • Driscoll Children's Hospital, Corpus Christi
  • McGovern Medical School, Houston
  • fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06672549

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

  • Amarillo Medical Specialists, Amarillo
  • Velocity Clinical Res-Dallas, Dallas
  • Care United Research, LLC, Forney
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07339423

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Gastroenterology Research of San Antonio, San Antonio
  • Southern Star Research Institute, San Antonio
  • Tyler Research Institute, Tyler
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • UT Southwestern Medical Center, Dallas
  • Juno Research, Houston
  • Activian Clinical Research, Kingwood
  • fi 7 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • IMA Clinical Research Austin, Austin
  • Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
  • Velocity Clinical Research, Dallas, Dallas
  • fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07282600

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • JCCT - Juno Bellaire Site, Bellaire
  • Epic Medical Research - DeSoto, DeSoto
  • Valley Institute of Research - Fort Worth, Fort Worth
  • fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

  • IMA Clinical Research Austin, Austin
  • FutureSearch Trials of Dallas, Dallas
  • PlanIt Research, PLLC, Houston
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07589608

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • FutureSearch Trials of Neurology, Austin
  • Sleep Therapy Research Center, San Antonio
  • Consano Clinical Research, LLC, Shavano Park
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07369011

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • The University of Texas Health Science Center at Houston, Bellaire
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
  • fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, DeSoto
  • Research Site, El Paso
  • Research Site, Houston
  • fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07784270

Semaglutide for Post-Smoking Cessation Weight Management

  • The University of Texas at Austin, Austin
  • The University of Texas Health Science Center at Houston, Houston
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Austin
  • AURORA-2 Clinical Site, Brownsville
  • AURORA-2 Clinical Site, DeSoto
  • fi 10 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • PharmaTex Research, LLC, Amarillo
  • Austin Heart, Austin
  • Javara Research, Conroe
  • fi 13 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07037459

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Austin
  • AURORA-1 Clinical Site, Brownsville
  • AURORA-1 Clinical Site, DeSoto
  • fi 8 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Headlands Research Brownsville, Brownsville
  • Velocity Clinical Research, Dallas
  • South Texas Research Institute - Edinburg, Edinburg
  • fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Juno Research, Houston
  • Southern Endocrinology Associates, Mesquite
  • Texas Diabetes & Endocrinology, P.A., Round Rock
  • fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Bellaire Clinical Research, LLC, Bellaire
  • South Texas Research Institute - Brownsville, Brownsville
  • South Texas Clinical Research, Corpus Christi
  • fi 8 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07351045

First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671

  • Research Site, Webster
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
Umuriin 25 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT07815678

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Austin
  • ACCOMPLISH-2 Research Site, Farmers Branch
  • ACCOMPLISH-2 Research Site, Houston
  • fi 4 dabalataa
Namoota walitti qabaa jiraSadarkaa 3Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07654374

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • Epic Medical Research, DeSoto
  • Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
  • Biorhythms Center for Integrative Sleep Medicine, El Paso
  • fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07571005

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • Epic Medical Research, DeSoto
  • Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
  • Biorhythms Center for Integrative Sleep Medicine, El Paso
  • fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07571109

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

  • Cedar Health Research, Dallas
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07770841

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
  • Biopharma Informatic, LLC, Houston
  • fi 5 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

  • IMA Clinical Research Austin, Austin
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
  • fi 3 dabalataa
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06143956

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.